7.8.02: Biotechnology Issue
Seven analysts and top management from forty five sector firms examine the Biotechnology sector in this 186 - page Special Focus - Biotechnology Issue from The Wall Street Transcript.

    Online subscribers to the Healthcare sector also get
    Sexual Dysfunction Issue

  1. Special Focus - Biotechnology - In an in-depth (10,400 words) Analyst Roundtable, Jonathan Aschoff, PhD. , a Senior Research Analyst at Friedman, Billings, Ramsey & Co., Franklin M. Berger, a Managing Director at J.P. Morgan H&Q, Joseph P. Dougherty, a Vice President at Lehman Brothers, Fariba Ghodsian, a Managing Director & Director of Healthcare Research at Roth Capital Partners, Alexander A. Hittle, CFA, a Senior Research Analyst at A.G. Edwards, Craig D. West, an Associate Vice President & Senior Biotech Analyst at A.G. Edwards, examine the outlook for the sector and share specific stock recommendations.
  2. CEO interviews (average 2,500 words). Top management of 45 - sector firms examine the outlook for their firm and the sector. Firms include:
    CollaGenex Pharmaceuticals, Neurobiological Technologies, Orchid Biosciences, Biogen, Boston Life Sciences, Cypress Bioscience, Caliper Technologies, Genaissance Pharmaceuticals, Harvard Bioscience, Hyseq Pharmaceuticals, Inspire Pharmacueticals, Ligand Pharmaceuticals
    3. ORDER THIS REPORT NOW! ONLY $175
    The report will be mailed first class. For fedex delivery, specify in the report details section and either include your fedex number or we will add $15 delivery charge. All sales are final.  Questions, call (212) 952-7433, or email us
    For immediate access online - click here to gain a password.
     
    Report details:  
    Your Name:  
    		 Company: 
    Address: 
    		 City: 
    State/Province:
    		 ZIP/Postal Code:
          		 Country:
    Phone:
    		 E-Mail:

    BILLING INFORMATION
    Credit Card
    		 Expiration Month/Year:
    Credit Card Number: 
     

     This Issue costs $175 - and is non-returnable.   

    The Wall Street Transcript does not endorse the views of any interviewee nor does it make stock recommendations.

     

Investors and Industry Execs.

The Wall Street Transcript has been used by investors and industry executives for 40 years as a unique tool for company and industry research.

TWST's roundtable panels and analyst interviews provide a sector perspective from Wall Street's best. 

Money manager interviews provide the view from the buy-side.

CEO interviews with hundreds of companies from the major sectors gives the company perspective right from the top.

Subscribe to a unique research tool for investors and industry executives. Call (212) 952 7433 or click here.

Sincerely,

Andrew Pickup
Publisher
HOME PRODUCTS SUBSCRIBE ABOUT ARCHIVE HOTLINE CONTACT EUROPE